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G-protein coupled receptors (GPCRs) play a key role in many complex biological processes, including 
regulation of stem cell pluripotency and differentiation. Signal transduction pathways that are activated 
during stem cell renewal and differentiation are shared, cross-activated or synergistic with GPCR 
stimulation [1]. 
Regulation of GPCR responses involved the activation of desensitization machinery, which started with 
phosphorylation of agonist-activated receptor by second messenger-dependent and/or GPCR kinases 
(GRKs)[1]. Besides controlling receptor responsiveness, GRKs can also act as agonist-regulated scaffolds 
assembling macromolecular signalosomes in the receptor environment, thereby contributing to signal 
propagation from cytosol to nucleus, and controlling gene transcription machinery [2].  
Recent evidence suggests that the desensitization machinery fulfils a vital role in regulating cellular 
responses to GPCRs, and that changes in expression/functioning of these regulatory proteins may be crucial 
in the control of cell differentiation program [3]. These data are consistent with the notion that GPCR 
responsiveness may be differentially regulated during cell differentiation. 
In our hands, two different cellular models (oligodendrocyte precursor cells, OPCs, and mesenchymal stem 
cells, MSCs) were used to investigate the role of the GPCR desensitisation machinery in stem cell 
differentiation. During OPC differentiation, defective control of the membrane receptor GPR17 has been 
suggested to block cell maturation and impairs remyelination under demyelinating conditions [4]. Here we 
show, for the first time, a role for Murine double minute 2 (Mdm2), a ligase previously involved in 
ubiquitination/degradation of p53 protein. In maturing OPCs, the inhibition of Mdm2-p53 interactions 
increased GRK2 sequestration by Mdm2, leading to impaired GPR17 down-regulation and OPC maturation 
block.  
In MSCs, the A2B adenosine receptor (A2BAR) has been recently emerged as the major AR involved in 
osteoblastogenesis [5]. Proinflammatory cytokines, such as Tumour Necrosis Factor- (TNF-, have been 
demonstrated to regulate MSC differentiation and bone remodelling. Herein, we show that TNF- 
diminished GRK2 levels in MSCs, thus blocking A2BAR desensitization. As a result, TNF- enhanced the 
A2BAR-mediated responses and favoured MSC differentiation to osteoblasts in response to receptor 
agonists.  
The findings get new insights for discovering of the signals at the basis of cell differentiation. 
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